Investors & Media

SEC Filing Details

Investor Relations Menu
Investor Home
News & Events
Press Releases Events & Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition
Investor Resources
Investor FAQs Investor Contact Email Alerts
Contact

Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com

Document Details

Form
EFFECT
Filing Date
Jul 29, 2020
Document Date
Jul 29, 2020
Form Description
EFFECT
Filing Group
Other
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download XLS